BRITER: A BMP responsive osteoblast reporter cell line

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Yadav, Prem Swaroop ^a   Prashar, Paritosh ^a   Bandyopadhyay, Amitabha ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; TAMOXIFEN; BONE MORPHOGENETIC PROTEIN;

ANIMAL CELL; ARTICLE; BMP RESPONSIVE IMMORTALIZED REPORTER CELL LINE; CELL ISOLATION; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; MOLECULAR GENETICS; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; METABOLISM; MOUSE MUTANT; REPORTER GENE;

VERTEBRATA;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE; GENES, REPORTER; HUMANS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; SIGNAL TRANSDUCTION;

EID: 84860999596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037134     Document Type: Article

References (50)

1. Urist MR, (1965) Bone: formation by autoinduction. Science 150: 893-899.
2. Massague J, (1996) TGFbeta signaling: receptors, transducers, and Mad proteins. Cell 85: 947-950.
3. Hogan BL, (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10: 1580-1594.
4. Sakou T, (1998) Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22: 591-603.
5. Luu HH, Song WX, Luo X, Manning D, Luo J, et al. (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25: 665-677.
6. Bandyopadhyay A, Tsuji K, Cox K, Harfe BD, Rosen V, et al. (2006) Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2: e216.
7. Attisano L, Wrana JL, (2000) Smads as transcriptional co-modulators. Curr Opin Cell Biol 12: 235-243.
8. Derynck R, Zhang Y, Feng XH, (1998) Smads: transcriptional activators of TGF-beta responses. Cell 95: 737-740.
9. Massague J, Wotton D, (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19: 1745-1754.
10. Korchynskyi O, ten Dijke P, (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277: 4883-4891.
11. Goto K, Kamiya Y, Imamura T, Miyazono K, Miyazawa K, (2007) Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors. J Biol Chem 282: 20603-20611.
12. Herrera B, Inman GJ, (2009) A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biol 10: 20.
13. Logeart-Avramoglou D, Bourguignon M, Oudina K, Ten Dijke P, Petite H, (2006) An assay for the determination of biologically active bone morphogenetic proteins using cells transfected with an inhibitor of differentiation promoter-luciferase construct. Anal Biochem 349: 78-86.
14. Zilberberg L, ten Dijke P, Sakai LY, Rifkin DB, (2007) A rapid and sensitive bioassay to measure bone morphogenetic protein activity. BMC Cell Biol 8: 41.
15. Bonatus T, Olson SA, Lee S, Chapman MW, (1997) Nonreamed locking intramedullary nailing for open fractures of the tibia. Clin Orthop Relat Res pp. 58-64.
16. Caudle RJ, Stern PJ, (1987) Severe open fractures of the tibia. J Bone Joint Surg Am 69: 801-807.
17. Edwards CC, Simmons SC, Browner BD, Weigel MC, (1988) Severe open tibial fractures. Results treating 202 injuries with external fixation. Clin Orthop Relat Res pp. 98-115.
18. Riemer BL, DiChristina DG, Cooper A, Sagiv S, Butterfield SL, et al. (1995) Nonreamed nailing of tibial diaphyseal fractures in blunt polytrauma patients. J Orthop Trauma 9: 66-75.
19. Sanders R, Jersinovich I, Anglen J, DiPasquale T, Herscovici D Jr, (1994) The treatment of open tibial shaft fractures using an interlocked intramedullary nail without reaming. J Orthop Trauma 8: 504-510.
20. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, et al. (2002) Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A: 2123-2134.
21. Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, et al. (2006) Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88: 1431-1441.
22. Poynton AR, Lane JM, (2002) Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976) 27: S40-48.
23. Saito N, Murakami N, Takahashi J, Horiuchi H, Ota H, et al. (2005) Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. Adv Drug Deliv Rev 57: 1037-1048.
24. Seeherman H, Wozney JM, (2005) Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16: 329-345.
25. Wozney JM, Rosen V, (1998) Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res pp. 26-37.
26. Badea TC, Cahill H, Ecker J, Hattar S, Nathans J, (2009) Distinct roles of transcription factors brn3a and brn3b in controlling the development, morphology, and function of retinal ganglion cells. Neuron 61: 852-864.
27. Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, et al. (2003) Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3: 483-495.
28. Hansen JB, Jorgensen C, Petersen RK, Hallenborg P, De Matteis R, et al. (2004) Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci U S A 101: 4112-4117.
29. Graham FL, van der Eb AJ, (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467.
30. Burstone MS, (1958) Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J Natl Cancer Inst 21: 523-539.
31. Burstone MS, (1958) Histochemical comparison of naphthol AS-phosphates for the demonstration of phosphatases. J Natl Cancer Inst 20: 601-615.
32. Puchtler H, Meloan SN, Terry MS, (1969) On the history and mechanism of alizarin and alizarin red S stains for calcium. J Histochem Cytochem 17: 110-124.
33. Bills CE, Eisenberg H, Pallante SL, (1971) Complexes of organic acids with calcium phosphate: the von Kossa stain as a clue to the composition of bone mineral. Johns Hopkins Med J 128: 194-207.
34. Chen D, Zhao M, Mundy GR, (2004) Bone morphogenetic proteins. Growth Factors 22: 233-241.
35. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, et al. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534.
36. Monteiro RM, de Sousa Lopes SM, Korchynskyi O, ten Dijke P, Mummery CL, (2004) Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins. J Cell Sci 117: 4653-4663.
37. Rickard DJ, Hofbauer LC, Bonde SK, Gori F, Spelsberg TC, et al. (1998) Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest 101: 413-422.
38. Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, et al. (2008) Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 588: 333-341.
39. van Bezooijen RL, Roelen BA, Visser A, van der Wee-Pals L, de Wilt E, et al. (2004) Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199: 805-814.
40. Ecarot-Charrier B, Glorieux FH, van der Rest M, Pereira G, (1983) Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J Cell Biol 96: 639-643.
41. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, et al. (1999) Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem 274: 31577-31582.
42. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, et al. (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783-8792.
43. Pardali E, Xie XQ, Tsapogas P, Itoh S, Arvanitidis K, et al. (2000) Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes. J Biol Chem 275: 3552-3560.
44. Zhang YW, Yasui N, Ito K, Huang G, Fujii M, et al. (2000) A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A 97: 10549-10554.
45. Bialkowska AB, Du Y, Fu H, Yang VW, (2009) Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening. Mol Cancer Ther 8: 563-570.
46. Kang MI, Henrich CJ, Bokesch HR, Gustafson KR, McMahon JB, et al. (2009) A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits". Mol Cancer Ther 8: 571-581.
47. Mushinski JF, Nguyen P, Stevens LM, Khanna C, Lee S, et al. (2009) Inhibition of tumor cell motility by the interferon-inducible GTPase MxA. J Biol Chem 284: 15206-15214.
48. DasGupta R, Kaykas A, Moon RT, Perrimon N, (2005) Functional genomic analysis of the Wnt-wingless signaling pathway. Science 308: 826-833.
49. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, et al. (2008) Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454: 890-893.
50. Wendler F, Gillingham AK, Sinka R, Rosa-Ferreira C, Gordon DE,et al. A genome-wide RNA interference screen identifies two novel components of the metazoan secretory pathway. EMBO J 29: 304-314.